Trademark: APTEGRA 2404052
Word
APTEGRA
ID
2404052
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
11 October 2023
Registration Date
11 October 2023
Renewal Date
11 October 2033
Owner(s)
Service
Goods and Services:
Class 42:
Biological research, clinical research and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; testing services in the field of antibodies; testing services for vaccines and medicines; research and development in the field of cell therapies; testing services for gene or cell therapies.
Biological research, clinical research and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; testing services in the field of antibodies; testing services for vaccines and medicines; research and development in the field of cell therapies; testing services for gene or cell therapies.